Literature DB >> 23430111

The adaptor molecule SAP plays essential roles during invariant NKT cell cytotoxicity and lytic synapse formation.

Rupali Das1, Hamid Bassiri, Peng Guan, Susan Wiener, Pinaki P Banerjee, Ming-Chao Zhong, André Veillette, Jordan S Orange, Kim E Nichols.   

Abstract

The adaptor molecule signaling lymphocytic activation molecule-associated protein (SAP) plays critical roles during invariant natural killer T (iNKT) cell ontogeny. As a result, SAP-deficient humans and mice lack iNKT cells. The strict developmental requirement for SAP has made it difficult to discern its possible involvement in mature iNKT cell functions. By using temporal Cre recombinase-mediated gene deletion to ablate SAP expression after completion of iNKT cell development, we demonstrate that SAP is essential for T-cell receptor (TCR)-induced iNKT cell cytotoxicity against T-cell and B-cell leukemia targets in vitro and iNKT-cell-mediated control of T-cell leukemia growth in vivo. These findings are not restricted to the murine system: silencing RNA-mediated suppression of SAP expression in human iNKT cells also significantly impairs TCR-induced cytolysis. Mechanistic studies reveal that iNKT cell killing requires the tyrosine kinase Fyn, a known SAP-binding protein. Furthermore, SAP expression is required within iNKT cells to facilitate their interaction with T-cell targets and induce reorientation of the microtubule-organizing center to the immunologic synapse (IS). Collectively, these studies highlight a novel and essential role for SAP during iNKT cell cytotoxicity and formation of a functional IS.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23430111      PMCID: PMC3637014          DOI: 10.1182/blood-2012-11-468868

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  44 in total

1.  The adaptor SAP controls NK cell activation by regulating the enzymes Vav-1 and SHIP-1 and by enhancing conjugates with target cells.

Authors:  Zhongjun Dong; Dominique Davidson; Luis Alberto Pérez-Quintero; Tomohiro Kurosaki; Wojciech Swat; André Veillette
Journal:  Immunity       Date:  2012-06-07       Impact factor: 31.745

2.  Positive and negative signaling through SLAM receptors regulate synapse organization and thresholds of cytolysis.

Authors:  Fang Zhao; Jennifer L Cannons; Mala Dutta; Gillian M Griffiths; Pamela L Schwartzberg
Journal:  Immunity       Date:  2012-06-07       Impact factor: 31.745

3.  Mas-related gene X2 (MrgX2) is a novel G protein-coupled receptor for the antimicrobial peptide LL-37 in human mast cells: resistance to receptor phosphorylation, desensitization, and internalization.

Authors:  Hariharan Subramanian; Kshitij Gupta; Qiang Guo; Ryan Price; Hydar Ali
Journal:  J Biol Chem       Date:  2011-11-08       Impact factor: 5.157

4.  Altered lymphocyte responses and cytokine production in mice deficient in the X-linked lymphoproliferative disease gene SH2D1A/DSHP/SAP.

Authors:  M J Czar; E N Kersh; L A Mijares; G Lanier; J Lewis; G Yap; A Chen; A Sher; C S Duckett; R Ahmed; P L Schwartzberg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-12       Impact factor: 11.205

5.  SAP expression in invariant NKT cells is required for cognate help to support B-cell responses.

Authors:  Cynthia Detre; Marton Keszei; Natividad Garrido-Mesa; Katalin Kis-Toth; Wilson Castro; Amma F Agyemang; Natacha Veerapen; Gurdyal S Besra; Michael C Carroll; George C Tsokos; Ninghai Wang; Elizabeth A Leadbetter; Cox Terhorst
Journal:  Blood       Date:  2012-05-21       Impact factor: 22.113

6.  TRAIL expression by activated human CD4(+)V alpha 24NKT cells induces in vitro and in vivo apoptosis of human acute myeloid leukemia cells.

Authors:  M Nieda; A Nicol; Y Koezuka; A Kikuchi; N Lapteva; Y Tanaka; K Tokunaga; K Suzuki; N Kayagaki; H Yagita; H Hirai; T Juji
Journal:  Blood       Date:  2001-04-01       Impact factor: 22.113

Review 7.  SLAM family receptors and SAP adaptors in immunity.

Authors:  Jennifer L Cannons; Stuart G Tangye; Pamela L Schwartzberg
Journal:  Annu Rev Immunol       Date:  2011       Impact factor: 28.527

8.  Conditional deletion of SLP-76 in mature T cells abrogates peripheral immune responses.

Authors:  Gregory F Wu; Evann Corbo; Michelle Schmidt; Jennifer E Smith-Garvin; Matthew J Riese; Martha S Jordan; Terri M Laufer; Eric J Brown; Jonathan S Maltzman
Journal:  Eur J Immunol       Date:  2011-06-07       Impact factor: 5.532

9.  T-cell receptor antagonists induce Vav phosphorylation by selective activation of Fyn kinase.

Authors:  J Huang; D Tilly; A Altman; K Sugie; H M Grey
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

10.  Molecular pathogenesis of EBV susceptibility in XLP as revealed by analysis of female carriers with heterozygous expression of SAP.

Authors:  Umaimainthan Palendira; Carol Low; Anna Chan; Andrew D Hislop; Edwin Ho; Tri Giang Phan; Elissa Deenick; Matthew C Cook; D Sean Riminton; Sharon Choo; Richard Loh; Frank Alvaro; Claire Booth; H Bobby Gaspar; Alessandro Moretta; Rajiv Khanna; Alan B Rickinson; Stuart G Tangye
Journal:  PLoS Biol       Date:  2011-11-01       Impact factor: 8.029

View more
  21 in total

1.  Protective Epitope Discovery and Design of MUC1-based Vaccine for Effective Tumor Protections in Immunotolerant Mice.

Authors:  Xuanjun Wu; Zhaojun Yin; Craig McKay; Christian Pett; Jin Yu; Manuel Schorlemer; Trevor Gohl; Suttipun Sungsuwan; Sherif Ramadan; Claire Baniel; Anthony Allmon; Rupali Das; Ulrika Westerlind; M G Finn; Xuefei Huang
Journal:  J Am Chem Soc       Date:  2018-11-19       Impact factor: 15.419

2.  mTORC2 regulates multiple aspects of NKT-cell development and function.

Authors:  Tammarah Sklarz; Peng Guan; Mercy Gohil; Renee M Cotton; Moyar Q Ge; Angela Haczku; Rupali Das; Martha S Jordan
Journal:  Eur J Immunol       Date:  2017-01-27       Impact factor: 5.532

3.  Enhancing the antitumor functions of invariant natural killer T cells using a soluble CD1d-CD19 fusion protein.

Authors:  Rupali Das; Peng Guan; Susan J Wiener; Nishant P Patel; Trevor G Gohl; Elizabeth Evans; Maurice Zauderer; Kim E Nichols
Journal:  Blood Adv       Date:  2019-03-12

4.  The adaptor protein SAP regulates type II NKT-cell development, cytokine production, and cytotoxicity against lymphoma.

Authors:  Xiufang Weng; Chia-Min Liao; Sreya Bagchi; Susanna L Cardell; Paul L Stein; Chyung-Ru Wang
Journal:  Eur J Immunol       Date:  2014-10-28       Impact factor: 5.532

5.  Genome Editing With TALEN, CRISPR-Cas9 and CRISPR-Cas12a in Combination With AAV6 Homology Donor Restores T Cell Function for XLP.

Authors:  Benjamin C Houghton; Neelam Panchal; Simone A Haas; Kay O Chmielewski; Markus Hildenbeutel; Thomas Whittaker; Claudio Mussolino; Toni Cathomen; Adrian J Thrasher; Claire Booth
Journal:  Front Genome Ed       Date:  2022-05-23

6.  EF Hand Domain Family Member D2 Is Required for T Cell Cytotoxicity.

Authors:  Michael Peled; Matthew A Dragovich; Kieran Adam; Marianne Strazza; Anna S Tocheva; Irving E Vega; Adam Mor
Journal:  J Immunol       Date:  2018-10-01       Impact factor: 5.422

7.  Expansion and CD2/CD3/CD28 stimulation enhance Th2 cytokine secretion of human invariant NKT cells with retained anti-tumor cytotoxicity.

Authors:  Kelly Andrews; Anouk A J Hamers; Xiaodian Sun; Geoffrey Neale; Katherine Verbist; Paige Tedrick; Kim E Nichols; Shalini Pereira; Daniel E Geraghty; Asha B Pillai
Journal:  Cytotherapy       Date:  2020-03-29       Impact factor: 5.414

8.  Janus kinase inhibition lessens inflammation and ameliorates disease in murine models of hemophagocytic lymphohistiocytosis.

Authors:  Rupali Das; Peng Guan; Leslee Sprague; Katherine Verbist; Paige Tedrick; Qi Angel An; Cheng Cheng; Makoto Kurachi; Ross Levine; E John Wherry; Scott W Canna; Edward M Behrens; Kim E Nichols
Journal:  Blood       Date:  2016-01-29       Impact factor: 22.113

Review 9.  Invariant natural killer T cells in hematopoietic stem cell transplantation: killer choice for natural suppression.

Authors:  P Guan; H Bassiri; N P Patel; K E Nichols; R Das
Journal:  Bone Marrow Transplant       Date:  2016-02-15       Impact factor: 5.174

Review 10.  Interferon-γ: teammate or opponent in the tumour microenvironment?

Authors:  Angela M Gocher; Creg J Workman; Dario A A Vignali
Journal:  Nat Rev Immunol       Date:  2021-06-21       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.